Comparative Safety Analysis of Serious Adverse Drug Events in North America: A 19-Year Study of FDA and Canadian Vigilance Databases

被引：0
|
作者：
Chalabianloo, Niaz [1 ,2 ,3 ]
Sedig, Kamran [3 ]
Muanda, Flory Tsobo [1 ,2 ,4 ,5 ]
机构：
[1] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada
[2] ICES Western, London, ON, Canada
[3] Western Univ, Dept Comp Sci, London, ON, Canada
[4] Lawson Hlth Res Inst, London, ON, Canada
[5] Western Univ, Dept Epidemiol Biostat, London, ON, Canada
来源：
DRUG SAFETY | 2024年 / 47卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
134
引用
收藏
页码：1376 / 1377
页数：2
相关论文
共 36 条
  • [21] Evaluation of the safety of intravesical BCG therapy in France: analysis of serious adverse events notified over a three-year period.
    Debois, H
    Loupi, E
    Saliou, P
    Blangy, H
    Loeuille, D
    Gillet, P
    PROGRES EN UROLOGIE, 2001, 11 (03): : 458 - 465
  • [22] Evaluation of the safety of intravesical BCG therapy in France: analysis of serious adverse events notified over a three-year period. Commentary
    Coulange, C
    PROGRES EN UROLOGIE, 2001, 11 (03): : 465 - 465
  • [23] A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
    Song, Yongfu
    Wang, Zhuang
    Wang, Na
    Xie, Xiaofei
    Zhu, Tieshi
    Wang, Yongji
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [24] A matter of safety: Fewer or more serious adverse drug events with lithium than other mood stabilisers? 17-year- follow-up on the LiSIE retrospective cohort study
    Truedson, Petra
    Ott, Michael
    Wahlstrom, Lisa
    Lundqvist, Robert
    Maripuu, Martin
    Lindmark, Krister
    Lieber, Ingrid
    Werneke, Ursula
    BIPOLAR DISORDERS, 2024, 26 : 42 - 42
  • [25] A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
    Zeitoun, Abeer
    Hallit, Souheil
    Chehade, Sirine
    Ibrahim, Aya
    Helali, Maya
    Allam, Carla
    Karam, Rita
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [26] A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
    Abeer Zeitoun
    Souheil Hallit
    Sirine Chehade
    Aya Ibrahim
    Maya Helali
    Carla Allam
    Rita Karam
    Journal of Pharmaceutical Policy and Practice, 16
  • [27] FIVE-YEAR SAFETY ANALYSIS OF SACUBITRIL/VALSARTAN: A COMPARATIVE ANALYSIS OF ADVERSE EVENTS IN RANDOMIZED CLINICAL TRIALS AND REAL-WORLD PHARMACOVIGILANCE
    Kim, Yee Soo
    Brar, Simerjeet
    D'Albo, Natalie
    Shah, Sachin
    Ganatra, Sarju
    Dani, Sourbha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 663 - 663
  • [28] Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries
    Antonio Cicione
    Antonio Nacchia
    Alessandro Guercio
    Carmen Gravina
    Antonio Franco
    Maria Chiara Grimaldi
    Giorgia Tema
    Riccardo Lombardo
    Andrea Tubaro
    Cosimo De Nunzio
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 765 - 771
  • [29] Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries
    Cicione, Antonio
    Nacchia, Antonio
    Guercio, Alessandro
    Gravina, Carmen
    Franco, Antonio
    Grimaldi, Maria Chiara
    Tema, Giorgia
    Lombardo, Riccardo
    Tubaro, Andrea
    De Nunzio, Cosimo
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (04) : 765 - 771
  • [30] Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study
    Lin, Wanlong
    Zeng, Yanbin
    Weng, Lizhu
    Yang, Jianhui
    Zhuang, Wei
    BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):
1234